Abstract:The dynamic RNA modifications have been viewed as new posttranscriptional regulator in modulating gene expression as well as in a broad range of physiological processes. N 1-methyladenosine (m1A) is one of the most prevalent modifications existing in multiple types of RNAs. In-depth investigation of the functions of m1A requires the site-specific assessment of m1A stoichiometry in RNA. Herein, we established a demethylase-assisted method (DA-m1A) for the site-specific detection and quantification of m1A in RNA. N1-methyl group in m1A could result in the stalling of reverse transcription at m1A site, thus producing the truncated cDNA. E. coli AlkB is a demethylase that can demethylate m1A to produce adenine in RNA, thus generating full-length cDNA from AlkB-treated RNA. Evaluation of the produced amounts of full-length cDNA by quantitative real-time PCR can achieve the site-specific detection and quantification of m1A in RNA. With the DA-m1A method, we examined and successfully confirmed the previously well-characterized m1A sites in various types of RNAs with low false positive rate. In addition, we found that the level of m1A was significantly decreased at the bromodomain containing 2 (BRD2) mRNA position 1674 and CST telomere replication complex component 1 (CTC1) mRNA position 5643 in human hepatocellular carcinoma tissues. The results suggest that these two m1A sites in mRNA may be involved in liver tumorigenesis. Taken together, the DA-m1A method is simple and enables the rapid, cost-effective, and site-specific detection and quantification of m1A in RNA, which provides a valuable tool to decipher the functions of m1A in human diseases.

N1-methyladenosine Formation, Gene Regulation, Biological Functions, and Clinical Relevance

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.

Research progress of N1-methyladenosine RNA modification in cancer

The emerging roles of N6-methyladenosine RNA methylation in human cancers

N1-methyladenosine Methylome in Messenger RNA and Non-Coding RNA.

N1-methyladenosine modification in cancer biology: Current status and future perspectives

N6-methyladenosine-mediated Gene Regulation and Therapeutic Implications.

N 1 -methyladenosine methylome in messenger RNA and non-coding RNA.

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Formation and removal of 1,N6-dimethyladenosine in mammalian transfer RNA.

Reversible RNA Modification N 1 -Methyladenosine (m 1 A) in Mrna and Trna

Formation and removal of 1, N 6-dimethyladenosine in mammalian transfer RNA

Demethylase-assisted site-specific detection of N1-methyladenosine in RNA

Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer

<i>N</i><SUP>6</SUP>-methyladenosine as a Novel Regulator of Brain Physiology and Diseases

RNA m 6 A methylation in cancer.

RNA epigenetic modification: N6-methyladenosine

N-6-Methyladenosine: A Novel RNA Imprint in Human Cancer

N6-Methyladenosine: A Novel RNA Imprint in Human Cancer

N 6 -Methyladenosine and Its Implications in Viruses